Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase I Study of TAS-106 in Combo With Carboplatin
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918
- Status
- TERMINATED
- Phase
- PHASE1
Hepatic Arterial Infusion (HAI) of Abraxane
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tor Kinase Inhibitor in Advanced Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of Bortezomib and Sunitinib
- Status
- COMPLETED
- Phase
- PHASE1
Characterisation of Gene Variants in the Angiogenic Pathway
- Status
- UNKNOWN
- Phase
- N/A
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1